KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Medpace Holdings (MEDP) over the last 6 years, with Q4 2025 value amounting to $28.8 million.

  • Medpace Holdings' Shares Outstanding (Weighted Average) fell 681.91% to $28.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.8 million, marking a year-over-year decrease of 681.91%. This contributed to the annual value of $28.8 million for FY2025, which is 681.91% down from last year.
  • According to the latest figures from Q4 2025, Medpace Holdings' Shares Outstanding (Weighted Average) is $28.8 million, which was down 681.91% from $29.0 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Shares Outstanding (Weighted Average) peaked at $35.9 million during Q4 2021, and registered a low of $28.8 million during Q4 2025.
  • Over the past 5 years, Medpace Holdings' median Shares Outstanding (Weighted Average) value was $31.0 million (recorded in 2024), while the average stood at $31.7 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first plummeted by 1119.77% in 2023, then surged by 105.46% in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Shares Outstanding (Weighted Average) stood at $35.9 million in 2021, then decreased by 9.69% to $32.4 million in 2022, then dropped by 5.14% to $30.7 million in 2023, then increased by 0.76% to $31.0 million in 2024, then dropped by 6.82% to $28.8 million in 2025.
  • Its last three reported values are $28.8 million in Q4 2025, $29.0 million for Q3 2025, and $29.5 million during Q2 2025.